Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300816 · ClinicalTrials.gov registry record · NA
Coping and Adjusting to Living With Multiple Sclerosis
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 242
- Enrollment target
NCT04300816: Completed NA study, sponsored by University of Washington.
NCT04300816 is a NA study that has completed, run by University of Washington. The registered enrollment target is 242 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04300816, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 242 participants
- Enrollment target
Study Summary
The purpose of this project is to test a brief, telephone-based psychological intervention, CBT-UT, to improve the ability to tolerate uncertainty-and thereby to reduce distress-in people with a recent diagnosis of Multiple Sclerosis (MS). There are three treatment arms for this study. Participants will receive either (1) CBT for Uncertainty Tolerance, (2) Traditional CBT, or (3) treatment as usual.
Primary Outcome
This is a self-reported measure of perceived MS Acceptance. Greater scores represent greater MS Acceptance.
Interventions
- BEHAVIORAL Traditional CBT
- BEHAVIORAL CBT for Uncertainty Tolerance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 242 participants |
| Start Date | 2019-10-30 |
| Est. Completion | 2022-11-11 |
| Phase | NA |
What the finished NCT04300816 record still lists
NCT04300816 is an interventional study that assigns participants to a tested intervention. The registered 242 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Traditional CBT is the first listed.
NCT04300816 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04300816 about?
NCT04300816 is a clinical study titled "Coping and Adjusting to Living With Multiple Sclerosis". The purpose of this project is to test a brief, telephone-based psychological intervention, CBT-UT, to improve the ability to tolerate uncertainty-and thereby to reduce distress-in people with a recent diagnosis of Multiple Sclerosis (MS). There are three treatment arms for this study. Participants ...
What is the current status of trial NCT04300816?
This trial is currently completed. It is a NA study. The enrollment target is 242 participants. The study started on 2019-10-30. Estimated completion is 2022-11-11.
What interventions are being tested in trial NCT04300816?
The interventions under investigation include: Traditional CBT (BEHAVIORAL), CBT for Uncertainty Tolerance (BEHAVIORAL).
Who is sponsoring clinical trial NCT04300816?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04300816's enrollment target sits among peer trials
242 439th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03556228 · 242 participants · Phase 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- NCT04260022 · 242 participants · Phase 1
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
- NCT04459000 · 242 participants · NA
Substance Use Treatment and Access to Resources (STARS) Project
- NCT05644496 · 242 participants · Phase 4
ZYNRELEF for Pain Management in Total Knee Arthroplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI